Eir Ventures has announced a strategic investment in RAPP, a digital platform improving postoperative care and recovery in Sweden.

Information on the Target

Founded in Sweden, RAPP emerged from the pioneering research of Professor Ulrica Nilsson. The company specializes in delivering an evidence-based, interactive, and patient-centric digital platform designed to enhance postoperative care and recovery. By focusing on the implementation of value-based care, RAPP seeks to improve overall patient satisfaction and quality of care following outpatient surgeries, commonly referred to as "day surgery."

RAPP's innovative monitoring system not only aims to elevate patient experiences but also enables healthcare systems to enhance workflow efficiency and reduce healthcare costs. Given the rising trend of same-day surgical procedures in recent years, the medical value generated by this digital platform is poised to benefit patients, healthcare providers, and the research community, fostering continuous improvements across the surgical landscape.

Industry Overview in Sweden

The healthcare sector in Sweden is renowned for its robust and efficient systems, consistently ranking among the best in the world. Sweden’s unique blend of public and private healthcare models provides comprehensive coverage to its citizens,

View Source

Similar Deals

Industrifonden Cellevate

2024

Seed Stage Biotechnology & Medical Research (NEC) Sweden
STOAF III SciTech Developeration AB

2023

Seed Stage Medical Devices & Implants Sweden
Flerie Invest Empros Pharma AB

2023

Seed Stage Proprietary & Advanced Pharmaceuticals Sweden
KTH Holding AB Glycolink AB

2023

Seed Stage Biotechnology & Medical Research (NEC) Sweden
Undisclosed Investors OlsAro

2023

Seed Stage Biotechnology & Medical Research (NEC) Sweden
Eir Ventures Strike Pharma

2023

Seed Stage Proprietary & Advanced Pharmaceuticals Sweden

Eir Ventures

invested in

RAPP

in 2023

in a Seed Stage deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert